Latest Health News

Thrive Tribe Technologies has raised approximately $300,000 through a discounted share placement, aiming to strengthen its working capital position. The move reflects ongoing efforts to support its health and wellness digital platform amid a competitive market.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

InhaleRx Limited has secured $427,500 from an initial tranche of its $1 million capital raise, issuing 17.1 million shares to support its inhaled therapies targeting pain and mental health conditions.

Carnegie Clean Energy’s Spanish subsidiary has received a significant pre-financing payment from the European Commission to advance innovations in wave energy technology through the COIN Project.

Race Oncology has raised $3.22 million through a private placement to fund its HARNESS-1 Phase 1a/b trial targeting non-small cell lung cancer, with patient enrolment expected early next year.

OMG Group has expanded its Blue Dinosaur protein bar distribution to 300 Metro Petroleum stores, reinforcing its growing presence in petrol and convenience retail channels ahead of the summer season.

Artrya Limited has landed a significant three-year commercial agreement with Northeast Georgia Health System, marking its second U.S. customer for the AI-powered Salix platform. This deal accelerates Artrya’s footprint in cardiovascular diagnostics across a major U.S. health network.

Talius Group appoints seasoned executive Pat Howard as CEO, with founder Graham Russell shifting to a strategic growth role, signalling a new phase of expansion and innovation.

RLF AgTech's second-year durian trial in Vietnam confirms a 38% yield increase and significant plant growth improvements, suggesting a potential 10-fold return on investment with minimal cost rise.

Matrix Composites & Engineering has fully redeemed its $7.5 million convertible note, replacing it with a new term loan facility from NAB that offers improved terms and a streamlined debt structure.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.